瑞思普利（874344）：公司拟对子公司珠海瑞思普利医药科技有限公司进行增资

Group 1 - The company announced a capital increase for its subsidiary Zhuhai Ruisi Puli Pharmaceutical Technology Co., Ltd., raising the registered capital from 240 million yuan to 276 million yuan by adding 36 million yuan [1] - The company plans to increase the registered capital of its subsidiary Shenzhen Ruiwan Biotechnology Co., Ltd. from 500,000 yuan to 2.5 million yuan by adding 2 million yuan [1] - Both capital increases will be fully subscribed in cash by the company and are expected to be completed by March 31, 2026 [1]